Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
72 studies found for:    Open Studies | "Spondylitis, Ankylosing"
Show Display Options
Rank Status Study
21 Recruiting Electroacupuncture for Relieving Pain in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Device: Electroacupuncture
22 Recruiting Anti-Tumor Necrosis Factor Therapy In Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Biological: TNF alpha;   Drug: NSAIDs and sulfasalazine
23 Recruiting The Colonic Microbiome and Mucosal Immunity in Inflammatory Bowel Disease and Ankylosing Spondylitis
Conditions: Inflammatory Bowel Diseases;   Ankylosing Spondylitis
Interventions: Procedure: Pinch biopsies;   Procedure: Flexible sigmoidoscopy
24 Recruiting An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention:
25 Not yet recruiting A Multicentre Study to Evaluate the Efficacy and Safety of ENIA11 in Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Biological: ENIA11;   Biological: Placebo
26 Recruiting 99mTc-rhAnnexin V-128 a Phase I/IIa Study in Patients With Rheumatoid Arthritis (RA) or Ankylosing Spondylitis (AS)
Conditions: Rheumatoid Arthritis;   Ankylosing Spondylitis
Intervention: Drug: 99mTc-rhAnnexin V-128
27 Recruiting Comparative Clinical Trial to Evaluate Efficacy and Safety of BCD-055 and Remicade® in Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Biological: BCD-055;   Biological: Remicade®
28 Unknown  Effects of Biological Treatment on Blood Pressure and Endothelial Function in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
Conditions: Rheumatoid Arthritis;   Psoriatic Arthritis;   Ankylosing Spondylitis;   Hypertension
Interventions: Drug: Etanercept;   Drug: Adalimumab;   Drug: Certolizumab;   Drug: Infliximab
29 Recruiting Interest of Continuous Non-Steroidal Anti-Inflammatory Drug Treatment in Ankylosing Spondylitis Patients Treated by Anti-TNF Therapy in the Prevention of Radiographic Outcomes
Condition: Ankylosing Spondylitis
Interventions: Drug: NSAIDs;   Drug: anti-TNF
30 Recruiting The Effect of NSAIDs Added to Anti-TNF Therapy Versus Anti-TNF Therapy Alone on Progression of Structural Damage in the Spine in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Biological: Golimumab;   Drug: Celecoxib
31 Recruiting Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice
Conditions: Rheumatoid Arthritis;   Ankylosing Spondylitis;   Psoriatic Arthritis;   Crohn´s Disease;   Ulcerative Colitis;   Plaque Psoriasis
Intervention:
32 Unknown  Assessment of SpondyloArthritis Society (ASAS) Classification and Diagnostic Criteria for Early Axial Spondyloarthritis (SpA)
Conditions: Spondyloarthritis;   Spondylarthropathy;   Spondylitis, Ankylosing
Intervention:
33 Unknown  Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Ankylosing Spondylitis (AS)
Condition: Ankylosing Spondylitis
Intervention: Biological: Human umbilical cord-derived MSCs
34 Recruiting Biopsychosocial Exploration of Pain Profiles in Inflammatory and Chronic Non-specific Axial Low Back Pain
Conditions: Back Pain;   Spondylitis, Ankylosing;   Low Back Pain
Intervention:
35 Recruiting Natural History and Development of Spondyloarthritis
Conditions: Arthritis;   Spondylitis, Ankylosing
Intervention:
36 Recruiting Biologic Treatment Registry Across Canada
Conditions: Arthritis, Rheumatoid;   Spondylitis, Ankylosing;   Arthritis, Psoriatic
Intervention:
37 Recruiting An Efficacy and Safety Study of Ustekinumab in Participants With Active Nonradiographic Axial Spondyloarthritis
Condition: Nonradiographic Axial Spondylitis, Ankylosing
Interventions: Drug: Group 1: Placebo;   Drug: Group 2: Ustekinumab 45 mg;   Drug: Group 3: Ustekinumab 90 mg
38 Recruiting Etanercept Withdrawal And Retreament Study In Subjects With Nr-ax SpA
Condition: Spondylitis, Ankylosing
Intervention: Biological: Etanercept
39 Recruiting Does Immunogenicity Have an Influence on the Efficacy of Anti-TNF Therapy in Patients With AS: An Inception Cohort Study
Conditions: Ankylosing Spondylitis;   Axial Spondyloarthritis
Intervention:
40 Recruiting Defining Remission With Etanercept in AS in Real Life Clinical Practice
Condition: Ankylosing Spondylitis
Intervention: Drug: etanercept

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years